DHX9-IN-9, identified by its CAS number 2973400-46-1, is a small molecule inhibitor that targets the DEAH-box helicase 9 (DHX9), a protein involved in various cellular processes, including RNA metabolism and gene expression regulation. This compound is characterized by its ability to modulate the activity of DHX9, potentially influencing pathways related to cancer and viral infections. As a selective inhibitor, DHX9-IN-9 may exhibit specific binding affinity to the target protein, which can be assessed through various biochemical assays. The compound's structure typically includes functional groups that enhance its solubility and bioavailability, making it suitable for in vitro and in vivo studies. Additionally, its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion (ADME), are crucial for evaluating its therapeutic potential. Research into DHX9-IN-9 may provide insights into novel therapeutic strategies for diseases where DHX9 plays a critical role, highlighting its significance in medicinal chemistry and drug development.

DHX9-IN-9

2973400-46-1: DHX9-IN-9, identified by its CAS number 2973400-46-1, is a small molecule inhibitor that targets the DEAH-box helicase 9 (DHX9), a protein involved in various cellular processes, including RNA metabolism and gene expression regulation. This compound is characterized by its ability to modulate the activity of DHX9, potentially influencing pathways related to cancer and viral infections. As a selective inhibitor, DHX9-IN-9 may exhibit specific binding affinity to the target protein, which can be assessed through various biochemical assays. The compound's structure typically includes functional groups that enhance its solubility and bioavailability, making it suitable for in vitro and in vivo studies. Additionally, its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion (ADME), are crucial for evaluating its therapeutic potential. Research into DHX9-IN-9 may provide insights into novel therapeutic strategies for diseases where DHX9 plays a critical role, highlighting its significance in medicinal chemistry and drug development.

<p>DHX9-IN-9 (509) acts as an inhibitor of the RNA helicase DHX9, demonstrating an EC50 of 0.0177 μM in DHX9 cellular target engagement, primarily utilized in cancer research [1].</p>

CAS 2973400-46-1

DHX9-IN-9

DHX9-IN-9

Ref: TM-T86205